The Aequitas Group is a boutique healthcare advisory firm that specializes in developing clinical and economic solutions that define product value to third-party payors, hospital administrators, investors, providers, and patients. Using their extensive technical expertise across the payor and purchaser landscape, our consultants identify market trends to position products for maximum patient access.
Historically, the payor was a customer in a tertiary position to providers and patients. However, payors’ influence continues to increase as scarce healthcare resources are allocated across new treatments and modalities. Manufacturers must establish a clear managed-markets strategy during the early stages of product development and commercialization planning. The Aequitas Group acts as a manufacturer’s managed-markets team member.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- theaequitasgroup.com
The Aequitas Group Questions
The Aequitas Group's website is theaequitasgroup.com
The Aequitas Group's LinkedIn profile is https://www.linkedin.com/company/the-aequitas-group
The Aequitas Group's industry is
Biotechnology Research
The Aequitas Group's top competitors are
Miotech Orthopedic Group, Llc,
Wcg Velos,
Immuno-Biological Laboratories Co., Ltd (Ibl),
Biogen,
Textrecruit (Acquired By Icims),
Pro-Spectus,
Specialized Technology Resources, Inc.,
Quality Care Metrics,
Calypte Biomedical Corporation,
Ocean Shore School.
The Aequitas Group's categories are Biotechnology Research
The Aequitas Group's founding year is 1999
